ProShares Ultra NASDAQ Biotechnology
18 hedge funds and large institutions have $1.92M invested in ProShares Ultra NASDAQ Biotechnology in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
83% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 6
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$293K | |
| 2 | +$31.9K | |
| 3 | +$5.63K | |
| 4 |
Morgan Stanley
New York
|
+$1.01K |
Top Sellers
| 1 | -$1.08M | |
| 2 | -$519K | |
| 3 | -$345K | |
| 4 |
TFA
Toth Financial Advisory
Leesburg,
Virginia
|
-$212K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$84.1K |
